What are the causes of hypocellular marrow?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hypocellular Marrow

Hypocellular marrow is primarily caused by aplastic anemia, but critical differential diagnoses include hypocellular myelodysplastic syndromes (H-MDS), hypocellular acute myeloid leukemia (H-AML), and secondary causes including drugs, toxins, infections, and inherited bone marrow failure syndromes. 1, 2

Primary Hematologic Causes

Aplastic Anemia (Most Common)

  • Idiopathic aplastic anemia accounts for the majority of hypocellular marrow cases, characterized by severely reduced cellularity (<20% in severe cases, age-corrected) with blast percentage below 1% 1, 3
  • Bone marrow shows fatty replacement of normal hematopoietic tissue without dysplasia or abnormal blast clusters 4, 3
  • Immune-mediated destruction of hematopoietic stem cells is the underlying mechanism in most cases 5

Hypocellular Myelodysplastic Syndromes (H-MDS)

  • Represents 7-29% of MDS cases (age-corrected: approximately 7%) and presents with hypocellular marrow but with unequivocal dysplasia distinguishing it from aplastic anemia 6
  • More common in Asian populations compared to Western populations 6
  • Features moderate to severe erythroid dysplasia, abnormal sideroblasts, and blast percentage of 5% or higher (in absence of significant dysplasia) 3
  • Critical distinction: Risk of progression to acute leukemia is much greater in H-MDS than aplastic anemia, making accurate diagnosis essential for treatment planning 6

Hypocellular Acute Myeloid Leukemia (H-AML)

  • Defined by ≥20% blasts on aspirate in a hypocellular setting, though this can be challenging to identify in inadequate aspirates 6
  • Presence of clusters of immature precursors (ALIP) in biopsy with absence of sufficient numbers of granulocytes establishes H-AML diagnosis 6, 3
  • Represents 2.2% of AML cases when age-corrected 6

Secondary and Acquired Causes

Toxic and Drug-Induced

  • Chemotherapy exposure, particularly alkylating agents and purine analogues, causes secondary hypocellular marrow 6
  • Benzene and its derivatives from occupational exposure 6, 7
  • Busulfan and chloramphenicol can induce bone marrow failure 7

Radiation and Environmental

  • Ionizing radiation and radiotherapy exposure 6
  • Occupational factors in agricultural and industrial workers 6

Infectious Causes

  • Viral infections can trigger immune-mediated bone marrow destruction 2, 7

Other Acquired Causes

  • Nutritional deficiencies (vitamin B12, folate) 2
  • Rheumatologic diseases 2
  • Paroxysmal nocturnal hemoglobinuria (PNH) - requires screening by sensitive flow cytometry 3

Inherited Bone Marrow Failure Syndromes

  • Fanconi anemia - more common in pediatric cases but can present in adults 6
  • Down syndrome and neurofibromatosis 6
  • Germline predisposition should be assessed in young adults or families with MDS, AML, or aplastic anemia 6, 8
  • Congenital cytopenias with late manifestation 5

Critical Diagnostic Pitfalls

Age correction is mandatory when assessing bone marrow cellularity - failure to correct for age dramatically overestimates hypocellular cases (from 13% to 2.2% in AML when corrected) 6, 1, 3

Blast count accuracy requires 500-cell differential - a 100-cell count has unacceptably wide confidence intervals (95% CI: 1.6-11.3% for a 5% blast count) versus 500-cell count (95% CI: 3.3-7.3%) 6

Misdiagnosis between aplastic anemia and H-MDS/H-AML leads to inappropriate treatment - aplastic anemia requires immunosuppression or transplant, while H-AML requires acute leukemia chemotherapy, and H-MDS has intermediate management 1, 3

Review by at least two observers is essential when diagnostic doubt exists, particularly for H-AML cases where concordance among experts is only 57% 6

References

Guideline

Management of Aplastic Anemia and Megaloblastic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Aplastic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aplastic Anemia and Leukopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Aplastic anemia].

Vnitrni lekarstvi, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Animal models for acquired bone marrow failure syndromes.

Clinical medicine & research, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.